• Subject: Re: Test
  • From: Chuck Lewis <clewis@xxxxxxxxxx>
  • Date: Mon, 24 Nov 1997 08:26:26 -0800

Works <BG>...

jovic@freenet.calgary.ab.ca wrote:

> Test
>
> * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
> * *
> * This is the RPG/400 Discussion Mailing List!  To submit a
> new         *
> * message, send your mail to "RPG400-L@midrange.com".  To
> unsubscribe   *
> * from this list send email to MAJORDOMO@midrange.com and
> specify       *
> * 'unsubscribe RPG400-L' in the body of your message.  Questions
> should *
> * be directed to the list owner / operator:
> david@midrange.com          *
> * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
> * *



--
Chuck


    _/_/_/_/   _/    _/   _/    _/   _/_/_/_/   _/    _/
   _/         _/    _/   _/    _/   _/         _/   _/
  _/         _/_/_/_/   _/    _/   _/         _/_/_/   Chuck Lewis
 _/         _/    _/   _/    _/   _/         _/   _/ CLEWIS@IQUEST.NET
_/_/_/_/   _/    _/   _/_/_/_/   _/_/_/_/   _/     _/ Indianapolis, IN

Home page at: http://www.bizcom.com/chucklewis

"The opinions that are shown, are exclusively my own. All my own, all my

own..." and NOT my employer's (with apologies to Emerson, Lake and
Palmer)...


* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
* This is the RPG/400 Discussion Mailing List!  To submit a new         *
* message, send your mail to "RPG400-L@midrange.com".  To unsubscribe   *
* from this list send email to MAJORDOMO@midrange.com and specify       *
* 'unsubscribe RPG400-L' in the body of your message.  Questions should *
* be directed to the list owner / operator: david@midrange.com          *
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *


This thread ...

Replies:

Follow On AppleNews
Return to Archive home page | Return to MIDRANGE.COM home page

This mailing list archive is Copyright 1997-2020 by midrange.com and David Gibbs as a compilation work. Use of the archive is restricted to research of a business or technical nature. Any other uses are prohibited. Full details are available on our policy page. If you have questions about this, please contact [javascript protected email address].